DUBLIN, Sept. 13, 2019 /PRNewswire/ -- X-BOLT Orthopaedics, a leading medical device company, today announced preliminary results from the largest ever multi-centre randomised controlled trial ...
X-Bolt Orthopaedics, a leading medical device company, announced preliminary results from the largest ever multi-centre randomised controlled trial comparing extracapsular hip fracture fixation ...
X-Bolt Orthopaedics, a leading medical device company, today announced the 1000 th patient has completed one-year of follow-up in the (n= 1,140 patients) multi-centre randomised controlled trial ...
Innovative Dublin-based hip fracture fixation company X-Bolt Orthopaedics has raised €1.8m in a seed-funding round led by AIB Seed Capital Fund. As well as AIB Seed Capital, which is co-managed by ...
Dublin medical-device company X-Bolt Orthopaedics has been granted a US patent for its novel device for fixing hip fractures. The US patent was granted just before Christmas and will remain in force ...
X-Bolt Orthopaedics, a leading medical device company, today announced the 1000 th patient has completed one-year of follow-up in the (n= 1,140 patients) multi-centre randomised controlled trial ...